Author Interviews, HPV, OBGYNE, Vaccine Studies / 24.06.2019

MedicalResearch.com Interview with: “Syringe and Vaccine” by NIAID is licensed under CC BY 2.0 Ali Moghtaderi PhD MBA Assistant Research Professor and Avi Dor PhD Professor of Health Policy and Economics Milken Institute School of Public Health George Washington University MedicalResearch.com: What is the background for this study? Response: In this study, we investigate the effect of Human Papillomavirus (HPV) vaccination on participation in Pap test, which is one of the most effective cancer screening interventions. Cervical cancers are causally linked to HPV infections. The Pap test is a diagnostic procedure for early detection of cervical cancer. HPV vaccination provides partial protection against cervical cancer, and the Pap test is strongly recommended for women 21 to 65 years of age even after vaccination. If vaccination leads to a reduction in testing participation, it could contribute to greater incidence and severity of cervical cancer. Note that we focus on relatively older women (age 22 or older) who were not vaccinated at younger ages. (more…)
Author Interviews, Cost of Health Care, General Medicine, JAMA, OBGYNE / 26.11.2013

dr_Deanna-Kepka MedicalResearch.com Interview with Deanna Kepka, PhD, MPH Assistant Professor College of Nursing & Huntsman Cancer Institute University of Utah MedicalResearch.com: What are the main findings of the study? Dr. Kepka: Nearly two-thirds, 64.8% (95% CI: 62.2% - 67.3%) of women reporting a hysterectomy also reported a recent Pap test since their hysterectomy and more than half, 58.4% (95% CI: 55.3% - 61.4%) of women age 65 years and older without a hysterectomy reported a Pap test in the past three years. Together, this represents approximately 14 million in the United States. (more…)